Company / Current Assets per Share
Myriad Genetics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.10
FY2025
5-year range
$3.73 / $6.87
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#148 of 210
Health Care
What the data says
At $4.10, Myriad Genetics, Inc.'s current assets per share ranks #148 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $3.73 in FY2024 to $6.87 in FY2021.
Based on SEC 10-K filings.
4.10 in FY2025 with a 5-year CAGR of -6.4%.
Remained stable around $4.10 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -6.4%
- 10-Year CAGR
- -
Sector benchmark
#148 of 210 in Health CareTop 70% of 210This company $4.10 Sector average $134.38
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 10.0% year-over-year.
- Ranks #148 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.10 | +10.0% |
| FY2024 | $3.73 | -10.4% |
| FY2023 | $4.16 | +11.3% |
| FY2022 | $3.74 | -45.6% |
| FY2021 | $6.87 | +20.6% |
| FY2020 | $5.69 | +12.8% |
| FY2019 | $5.04 | +6.1% |
| FY2018 | $4.75 | +15.8% |
| FY2017 | $4.10 | +5.2% |
| FY2016 | $3.90 | +13.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026